Delhi HC upholds rejection of Novo Nordisk’s injunction plea; Allows Dr. Reddy’s to manufacture and import ‘Semaglutide’
“Viewed from the perspective of a person in the know, it is prima facie clear that Semaglutide would be obvious from the teachings contained in the Genius Patent and that, therefore, a credible challenge to the validity of the suit patent, under Section 64(1)(f), is made out.”